SPARC Levels Modulate the Capacity of Mitomycin to Inhibit the Proliferation of Human Tenon’s Capsule Fibroblasts

Purpose. To evaluate the role of SPARC in the antiproliferation effect of MMC on human Tenon’s fibroblasts (HTF). Method. Sixteen PACG patients aged 59 ± 10 years (31–72 years), including 6 males and 10 females, were recruited. Tenon tissue was harvested during filtering surgery. Cell density was ev...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuanyuan Guo, Shouxiang Ni, Weiyan Zhou, Jiangping Hou, Jiaquan Shen
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2020/5703286
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550570643161088
author Yuanyuan Guo
Shouxiang Ni
Weiyan Zhou
Jiangping Hou
Jiaquan Shen
author_facet Yuanyuan Guo
Shouxiang Ni
Weiyan Zhou
Jiangping Hou
Jiaquan Shen
author_sort Yuanyuan Guo
collection DOAJ
description Purpose. To evaluate the role of SPARC in the antiproliferation effect of MMC on human Tenon’s fibroblasts (HTF). Method. Sixteen PACG patients aged 59 ± 10 years (31–72 years), including 6 males and 10 females, were recruited. Tenon tissue was harvested during filtering surgery. Cell density was evaluated after MMC application with different concentrations and application times, by which the optimized MMC application modality was determined. MMC, si-SPARC, or SPARC protein was used when needed to evaluate the cell densities under different conditions, by which the role of SPARC in MMC-mediated antifibrotic process was identified. Results. Considering that the cell densities, as well as SPARC expression on mRNA and protein levels, are relatively stable when the MMC concentration is higher than 0.02% and exposure time longer than 90 s, we chose the MMC application pattern with 0.02% and 90 s as an optimized pattern for the downstream work. Compared to control, the si-SPARC and MMC downregulated the SPARC protein by 91% (P<0.01) and 65% (P<0.01) and mRNA by 96% (P<0.01) and 64% (P<0.01), respectively. MMC decreases the cell densities by 53.50% compared to control. si-SPARC + MMC dramatically deceased the cell density no matter compared to the control group (P<0.01) or MMC group (P<0.01); correspondingly, the relative collagen gel area in the MMC + si-SPARC group was higher than that in the MMC group or si-SPARC group (P<0.05). The reactive oxygen species expression in the MMC + si-SPARC group is higher than that in the MMC group (P<0.05). Conclusion. This study demonstrates that in HTF, (1) MMC downregulates the expression of SPARC in protein and mRNA levels; (2) SPARC depletion has synergistic effect on the antifibrotic effect of MMC; and (3) reactive oxygen species are the possible mediator in the antifibrotic effect of MMC and si-SPARC.
format Article
id doaj-art-8bacb6ab73744399ba50eb17345760f9
institution Kabale University
issn 2090-004X
2090-0058
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-8bacb6ab73744399ba50eb17345760f92025-02-03T06:06:26ZengWileyJournal of Ophthalmology2090-004X2090-00582020-01-01202010.1155/2020/57032865703286SPARC Levels Modulate the Capacity of Mitomycin to Inhibit the Proliferation of Human Tenon’s Capsule FibroblastsYuanyuan Guo0Shouxiang Ni1Weiyan Zhou2Jiangping Hou3Jiaquan Shen4Department of Ophthalmology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, ChinaDepartment of Ophthalmology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, ChinaDepartment of Ophthalmology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, ChinaDepartment of Ophthalmology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, ChinaDepartment of Ophthalmology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, ChinaPurpose. To evaluate the role of SPARC in the antiproliferation effect of MMC on human Tenon’s fibroblasts (HTF). Method. Sixteen PACG patients aged 59 ± 10 years (31–72 years), including 6 males and 10 females, were recruited. Tenon tissue was harvested during filtering surgery. Cell density was evaluated after MMC application with different concentrations and application times, by which the optimized MMC application modality was determined. MMC, si-SPARC, or SPARC protein was used when needed to evaluate the cell densities under different conditions, by which the role of SPARC in MMC-mediated antifibrotic process was identified. Results. Considering that the cell densities, as well as SPARC expression on mRNA and protein levels, are relatively stable when the MMC concentration is higher than 0.02% and exposure time longer than 90 s, we chose the MMC application pattern with 0.02% and 90 s as an optimized pattern for the downstream work. Compared to control, the si-SPARC and MMC downregulated the SPARC protein by 91% (P<0.01) and 65% (P<0.01) and mRNA by 96% (P<0.01) and 64% (P<0.01), respectively. MMC decreases the cell densities by 53.50% compared to control. si-SPARC + MMC dramatically deceased the cell density no matter compared to the control group (P<0.01) or MMC group (P<0.01); correspondingly, the relative collagen gel area in the MMC + si-SPARC group was higher than that in the MMC group or si-SPARC group (P<0.05). The reactive oxygen species expression in the MMC + si-SPARC group is higher than that in the MMC group (P<0.05). Conclusion. This study demonstrates that in HTF, (1) MMC downregulates the expression of SPARC in protein and mRNA levels; (2) SPARC depletion has synergistic effect on the antifibrotic effect of MMC; and (3) reactive oxygen species are the possible mediator in the antifibrotic effect of MMC and si-SPARC.http://dx.doi.org/10.1155/2020/5703286
spellingShingle Yuanyuan Guo
Shouxiang Ni
Weiyan Zhou
Jiangping Hou
Jiaquan Shen
SPARC Levels Modulate the Capacity of Mitomycin to Inhibit the Proliferation of Human Tenon’s Capsule Fibroblasts
Journal of Ophthalmology
title SPARC Levels Modulate the Capacity of Mitomycin to Inhibit the Proliferation of Human Tenon’s Capsule Fibroblasts
title_full SPARC Levels Modulate the Capacity of Mitomycin to Inhibit the Proliferation of Human Tenon’s Capsule Fibroblasts
title_fullStr SPARC Levels Modulate the Capacity of Mitomycin to Inhibit the Proliferation of Human Tenon’s Capsule Fibroblasts
title_full_unstemmed SPARC Levels Modulate the Capacity of Mitomycin to Inhibit the Proliferation of Human Tenon’s Capsule Fibroblasts
title_short SPARC Levels Modulate the Capacity of Mitomycin to Inhibit the Proliferation of Human Tenon’s Capsule Fibroblasts
title_sort sparc levels modulate the capacity of mitomycin to inhibit the proliferation of human tenon s capsule fibroblasts
url http://dx.doi.org/10.1155/2020/5703286
work_keys_str_mv AT yuanyuanguo sparclevelsmodulatethecapacityofmitomycintoinhibittheproliferationofhumantenonscapsulefibroblasts
AT shouxiangni sparclevelsmodulatethecapacityofmitomycintoinhibittheproliferationofhumantenonscapsulefibroblasts
AT weiyanzhou sparclevelsmodulatethecapacityofmitomycintoinhibittheproliferationofhumantenonscapsulefibroblasts
AT jiangpinghou sparclevelsmodulatethecapacityofmitomycintoinhibittheproliferationofhumantenonscapsulefibroblasts
AT jiaquanshen sparclevelsmodulatethecapacityofmitomycintoinhibittheproliferationofhumantenonscapsulefibroblasts